D-Serine inhibits serine palmitoyltransferase, the enzyme catalyzing the initial step of sphingolipid biosynthesis  by Hanada, Kentaro et al.
D-Serine inhibits serine palmitoyltransferase, the enzyme catalyzing the
initial step of sphingolipid biosynthesis
Kentaro Hanadaa;b;*, Tomoko Haraa;b, Masahiro Nishijimaa
aDepartment of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
bCREST, Japan Science and Technology Corporation, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
Received 30 March 2000; received in revised form 28 April 2000
Edited by Shozo Yamamoto
Abstract Serine palmitoyltransferase (SPT), responsible for
the initial step of sphingolipid biosynthesis, catalyzes condensa-
tion of palmitoyl coenzyme A and L-serine to produce 3-
ketodihydrosphingosine (KDS). For determination of the stereo-
chemical specificity of the amino acid substrate, a competition
analysis of the production of [3H]KDS from L-[3H]serine was
performed using purified SPT. D-Serine inhibited [3H]KDS
production as effectively as non-radioactive L-serine, whereas
neither D-alanine nor D-threonine showed any significant effect.
Incubation of purified SPT with [palmitoyl 1-14C]palmitoyl
coenzyme A and D-serine did not produce [14C]KDS, while the
control incubation with L-serine did. These results suggest that
D-serine competes with L-serine for the amino acid recognition
site of SPT, but that D-serine is not utilized by this enzyme to
produce KDS.
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1. Introduction
Sphingolipids are ubiquitous constituents of membrane lip-
ids in mammalian cells, and are also distributed widely in
other animals, plants, and microbes [1]. Sphingolipid biosyn-
thesis is initiated by condensation of L-serine with palmitoyl
coenzyme A (CoA) to generate 3-ketodihydrosphingosine
(KDS), which is a reaction catalyzed by serine palmitoyltrans-
ferase (SPT), a pyridoxal phosphate-dependent enzyme em-
bedded in the endoplasmic reticulum ([2^4] and references
therein). The SPT enzyme consists of two subunits, 53-kDa
LCB1 and 63-kDa LCB2, with a 1:1 stoichiometry [4]. The
LCB2 subunit, but not the LCB1, has a conserved motif, in
which a lysine residue has been speculated to bind to a pyr-
idoxal phosphate group [5^10], although both subunits re-
quire expression of the SPT activity [5,6,10^12]. Substrate
speci¢city analysis with a puri¢ed enzyme has shown that
SPT preferentially uses palmitoyl CoA as the acyl CoA sub-
strate and speci¢cally serine as the amino acid substrate [4].
Recently, D-serine has been demonstrated to exist naturally
in the brain [13,14], in which sphingolipids are relatively abun-
dant as compared with other tissues [15,16]. Thus, in the
present study, we examined the stereochemical speci¢city of
the amino acid substrate for SPT, and showed that D-serine is
a competitive inhibitor of L-serine in the SPT reaction.
2. Materials and methods
2.1. Materials
L-Serine, D-alanine, D-threonine, and palmitoyl CoA were pur-
chased from Sigma, and D-serine was from Peptide Institute Inc.
(Osaka, Japan). L-[3H(G)]serine (20 Ci/mmol) and [palmitoyl
1-14C]palmitoyl CoA (55 mCi/mmol) were from American Radiola-
beled Chemicals.
2.2. Puri¢cation of SPT
The LY-B strain is a Chinese hamster ovary (CHO) cell mutant
lacking the endogenous LCB1 subunit [11], and LY-B/FHcLCB1 is
an LY-B transformant stably expressing a FLAG- and His6-peptide
tagged version of the hamster LCB1 protein [4]. SPT was puri¢ed
from LY-B/FHcLCB1 cells, as described previously [4]. In brief, mem-
branes prepared from LY-B/FHcLCB1 cells were solubilized by a
non-ionic detergent sucrose monolaurate, and then active SPT was
puri¢ed from the solubilized membrane fraction to homogeneity by
a⁄nity peptide chromatography.
2.3. Assay of SPT activity
Puri¢ed SPT (25 ng protein) was incubated in 200 Wl of a standard
SPT reaction bu¡er (50 mM HEPES^NaOH bu¡er (pH 7.5) contain-
ing 5 mM EDTA, 5 mM dithiothreitol, 50 WM pyridoxal phosphate,
25 WM palmitoyl CoA, and 0.1 mM L-[3H(G)]serine (50 mCi/mmol))
at 37‡C for 10 min. After stopping the reaction, lipids were extracted
and the radioactivity of the [3H]KDS that formed was measured, as
described previously [2]. Radioactivity extracted from enzyme-minus
controls was regarded as a background control.
3. Results
3.1. D-Serine inhibits SPT
Using assays to determine whether the production of
[3H]KDS from 0.1 mM L-[3H]serine with puri¢ed SPT was
inhibited by excess amounts of non-radioactive competitors,
we have recently shown that neither L-alanine, L-threonine,
L-serinamide, D,L-serinol, nor L-serine methylester serves as a
strong competitor against the production of [3H]KDS, indi-
cating that all of the amino, carboxyl, and hydroxyl groups of
L-serine are responsible for the substrate recognition of the
enzyme [4]. In the present study, we used a competition assay
to examine the stereochemical speci¢city of the amino acid
substrate for SPT activity. When 5 mM D-serine was used
as a competitor, [3H]KDS formation was inhibited by 90%,
similar to the result with 5 mM non-radioactive L-serine (Fig.
1). D-Alanine and D-threonine, however, were ine¡ective (Fig.
1A). A dose-response analysis determined that a concentra-
tion caused 50% inhibition (IC50) of D-serine for [3H]KDS
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production was 0.3 mM, which was almost identical to the
IC50 of L-serine (Fig. 1B). This unexpected nature of SPT was
not due to a possible partial denaturation of the enzyme dur-
ing puri¢cation, because similar inhibitory e¡ects of D-serine
were observed when intact membranes from wild-type CHO-
K1 and bovine brain cells were used as enzyme sources (data
not shown). This e¡ect of D-serine was also not due to con-
taminated L-serine, which unavoidably exists in commercially
available D-serine to a certain extent, because the level of L-
serine in the D-serine reagent used was less than 0.6% (mol/
mol) (personal communication from the manufacturer, Pep-
tide Institute Inc.). D-Serine obtained from a di¡erent supplier
(Sigma) also inhibited SPT activity (data not shown),
although the level of L-serine in the D-serine reagent from
Sigma was unknown.
To test whether the inhibition mode by D-serine was com-
petitive with L-serine, the in£uence of D-serine on double re-
ciprocal kinetic plots of KDS formation from L-serine was
examined. Compared with plots obtained at various L-serine
concentrations in the absence of D-serine, addition of 0.3 mM
D-serine to the SPT reaction mixture did not cause any reduc-
tion of the apparent Vmax value, but caused a change in the
slope of the plots (Fig. 1C), suggesting that D-serine inhibited
the SPT reaction in a competitive manner to L-serine.
3.2. D-Serine is not a productive substrate of SPT
To address the question whether D-serine serves as a sub-
strate of SPT to produce KDS, puri¢ed SPT was incubated
with 25 WM [palmitoyl 1-14C]palmitoyl CoA in the presence of
1 mM D- or L-serine, and radioactive lipid products of the
reaction were analyzed by TLC. When incubated with D-ser-
ine, the radioactive lipid patterns were the same as those of
the negative control without any serine (Fig. 2, lane 3 vs. 5),
although a radioactive compound co-migrating with standard
KDS was produced when incubated with L-serine (Fig. 2, lane
4). These results demonstrated that D-serine is not a produc-
tive substrate of SPT.
4. Discussion
In the course of the competition assay of the SPT reaction
with the puri¢ed enzyme, we unexpectedly found that D-serine
inhibited [3H]KDS formation with an IC50 of V0.3 mM (Fig.
1B), which is a value similar to the Km of L-serine for the SPT
reaction [4]. The mode of inhibition for [3H]KDS formation
by D-serine appears to be competition with L-[3H]serine (Fig.
1C). There was a slight possibility that the inhibition of
[3H]KDS production from L-[3H]serine by D-serine was due
to a simple dilution e¡ect of non-radioactive L-serine, which
might have been produced by isomerization of D-serine during
the assay. However, this possibility was eliminated by the
observation that incubation of puri¢ed SPT with D-serine
and radioactive palmitoyl CoA produced no KDS (Fig. 2).
These results suggest that D-serine competes with L-serine
Fig. 1. E¡ects of D-amino acids on the formation of [3H]KDS from
L-[3H]serine. A: Puri¢ed SPT (25 ng protein) was incubated in the
SPT reaction bu¡er containing 0.1 mM L-[3H]serine (50 mCi/mmol)
and 5 mM each of the non-radioactive competitors indicated at
37‡C for 10 min. The radioactivity of the [3H]KDS that formed was
measured as described in Section 2. Data from three experiments
are shown as the percentage of the mean radioactivity of [3H]KDS
formed in the absence of the competitors. B: Puri¢ed SPT (25 ng
protein) was incubated in the SPT reaction bu¡er containing
0.1 mM L-[3H]serine (50 mCi/mmol) and various concentrations of
non-radioactive D-serine (closed circles) or L-serine (open circles) at
37‡C for 10 min. Data are shown as the percentage of radioactivity
of [3H]KDS formed without addition of non-radioactive serine. C:
Puri¢ed SPT (25 ng protein) was incubated in the SPT reaction
bu¡er containing various concentrations of L-[3H]serine in the pres-
ence (closed circles) or absence (open circles) of 0.3 mM D-serine at
37‡C for 10 min. Data obtained are shown as double reciprocal
plots.
Fig. 2. SPT did not produce KDS from palmitoyl CoA and D-ser-
ine. Puri¢ed SPT (40 ng protein) was incubated in 200 Wl of 50 mM
HEPES^NaOH (pH 7.5) containing 25 WM [palmitoyl-1-14C]-
palmitoyl CoA (55 mCi/mmol), 50 WM pyridoxal phosphate, 5 mM
EDTA, and 5 mM dithiothreitol in the presence or absence of 1 mM
L- or D-serine at 37‡C for 10 min. As an enzyme-minus control, ve-
hicle bu¡er was added in place of the enzyme. Radioactive lipids
were then extracted and separated by TLC with a solvent of chloro-
form/methanol/2 N ammonia (80/20/2, by volume). Radioactive lip-
ids on the TLC plate were visualized by image analysis. The mobil-
ity of the standard [14C]KDS, which was formed by the SPT
reaction with L-[U-14C]serine (158 mCi/mmol; Amersham Pharmacia
Biotech) is shown by the arrow. Lanes 1 and 2, 1 mM L-serine and
D-serine, respectively, without the enzyme; lanes 3^5, no serine,
1 mM L-serine, and 1 mM D-serine, respectively, with puri¢ed SPT.
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for the amino acid recognition site of SPT, although D-serine
is not utilized by SPT to produce KDS.
Recognition of L-serine by SPT is likely to involve Schi¡-
base formation between the amino acid substrate and a pyr-
idoxal phosphate-group in the enzyme [17,18]. Binding of
both enantiomers of a compound to one enzyme is exception-
al, but not inconceivable for pyridoxal phosphate-dependent
enzymes. For example, serine racemase, a pyridoxal phos-
phate-dependent enzyme, recognizes both L- and D-serine,
and catalyzes the conversion of L-serine to D-serine and vice
versa [19]. Thus, the SPT enzyme is presumably able to form
Schi¡-base complexes with both enantiomers of serine,
although in the postulated next reaction, substitution of the
K-hydrogen atom of serine by the palmitoyl group of palmi-
toyl CoA [17,18], may proceed in the Schi¡-base complex with
L-serine, but not D-serine (Fig. 3).
Sphingolipids synthesized via SPT reaction in intact cells
can be metabolically labeled by incubation of the cells with
radioactive L-serine [4,10]. Addition of an excess amount (10
mM) of non-radioactive L-serine to a metabolic labeling me-
dium containing L-[14C]serine inhibited formation of radioac-
tive sphingolipids in CHO cells almost completely, whereas 10
mM D-serine caused only slight inhibition (our unpublished
observation), probably due to the ine⁄cient uptake of D-ser-
ine into cells. However, it has recently been revealed that
substantial quantities of D-serine are present in discrete areas
of the brain [13,14]. In such speci¢c cell types, D-serine is
synthesized from L-serine by serine racemase, a cytosolic en-
zyme [19,20]. Therefore, our ¢nding that D-serine inhibits in
vitro SPT activity raises the previously unrecognized possibil-
ity that D-serine a¡ects sphingolipid synthesis in certain cell
types enriched by it, although further studies are needed to
elucidate the physiological relevance of the inhibition of the
SPT reaction by D-serine.
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Fig. 3. A postulated mechanism of inhibition of the SPT reaction
by D-serine. The Lys residue bound to pyridoxal phosphate in ham-
ster SPT is predicted to be Lys377 in the LCB2 subunit [10].
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